Kristina Matthews
Physician Assistant · Salisbury, MDNPI 1942512264
Payments from drug & device makers
Across 250 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$623
- AbbVie$602
- GSK$385
- Amgen$289
- AstraZeneca$282
- Boehringer Ingelheim$204
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,408100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 37 | $623 |
| AbbVie | 37 | $602 |
| GSK | 19 | $385 |
| Amgen | 17 | $289 |
| AstraZeneca | 17 | $282 |
| Boehringer Ingelheim | 13 | $204 |
| Pfizer | 10 | $183 |
| Exact Sciences | 7 | $149 |
| Novo Nordisk | 9 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $111 |
| Phathom Pharmaceuticals, Inc. | 6 | $111 |
| Kowa Pharmaceuticals America, Inc. | 6 | $106 |
| Astellas Pharma US Inc | 5 | $101 |
| Viiv Healthcare Company | 5 | $90 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $86 |
| Medtronic | 3 | $82 |
| Merck | 5 | $75 |
| Novartis | 5 | $74 |
| Amarin Pharma, Inc. | 4 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| Corcept Therapeutics | 4 | $65 |
| Johnson & Johnson | 3 | $62 |
| Dexcom, Inc. | 3 | $62 |
| Idorsia Pharmaceuticals US Inc | 3 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Bayer | 2 | $42 |
| Atricure, Inc. | 1 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Abbott | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| BD | 1 | $21 |
| Electromed, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Pharming Healthcare, Inc. | 1 | $14 |
How this compares
$4,408 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 92 | $100,300 |
| MounjaroTirzepatide | 38 | $47,535 |
| TrulicityDulaglutide | 37 | $39,850 |
| RybelsusSemaglutide | 14 | $33,381 |
| EliquisApixaban | 21 | $33,118 |
| XareltoRivaroxaban | 36 | $22,783 |
| FarxigaDapagliflozin Propanediol | 20 | $22,270 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $15,677 |
| JanuviaSitagliptin Phosphate | 20 | $13,140 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $9,298 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $6,894 |
| LinzessLinaclotide | 11 | $6,813 |
| TradjentaLinagliptin | 11 | $6,413 |
| MyrbetriqMirabegron | 13 | $5,875 |
| Rosuvastatin Calcium | 164 | $4,369 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $204 | $106,713103 claims |
| Lilly USA, LLCMounjaro, Trulicity | $623 | $87,38575 claims |
| Novo NordiskRybelsus | $143 | $33,38114 claims |
| PfizerEliquis | $183 | $33,11821 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $385 | $24,97522 claims |
| Johnson & JohnsonXarelto | $62 | $22,78336 claims |
| AstraZenecaFarxiga | $282 | $22,27020 claims |
| MerckJanuvia | $75 | $13,14020 claims |
| AbbVieLinzess, Synthroid | $602 | $8,38839 claims |
| Astellas Pharma US IncMyrbetriq | $101 | $5,87513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Salisbury
- Brittany YerkesSalisbury$81K
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Michael RitmillerOwings Mills$92K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Bruce SmithBaltimore$63K
- Shannon MarriottBaltimore$38K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.